Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The New York Proton Center
University of Arizona
Pfizer
National Institutes of Health Clinical Center (CC)
Conjupro Biotherapeutics, Inc.
Pfizer
Dragonfly Therapeutics
PMV Pharmaceuticals, Inc
Hoffmann-La Roche
ViroMissile, Inc.
Luzerner Kantonsspital
Duke University
Tizona Therapeutics, Inc
IDEAYA Biosciences
University of Colorado, Denver
Adaptimmune
Daiichi Sankyo
Oscotec Inc.
Kidney Cancer Research Bureau
Second Life Therapeutics
Novartis
Inhibrx Biosciences, Inc
RenJi Hospital
Gustave Roussy, Cancer Campus, Grand Paris
National Institutes of Health Clinical Center (CC)
BicycleTx Limited
University of Colorado, Denver
Bolt Biotherapeutics, Inc.
Tempus AI
UNC Lineberger Comprehensive Cancer Center
ITM Oncologics GmbH
Actym Therapeutics, Inc.
Maastricht University Medical Center
Maastricht Radiation Oncology
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Exelixis
Institut Cancerologie de l'Ouest
Sensei Biotherapeutics, Inc.
MacroGenics
Incyte Corporation
The Netherlands Cancer Institute
Brigham and Women's Hospital
Marengo Therapeutics, Inc.
Genentech, Inc.
ModeX Therapeutics, An OPKO Health Company
Celldex Therapeutics
Cancer Research UK
UNICANCER